# US 2019/0316068 A1 · Engineered platform to generate 3d cardiac tissues

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0316068 A1
- Document ID: US20190316068A1
- Status: Published application
- Kind: A1
- Application number: 16/381,866
- Filed: 2019-04-11
- Published: 2019-10-17
- Earliest claimed: 2018-04-11
- Assignees: Trustees of Boston University
- Applicants: Trustees of Boston University
- Inventors: Christopher S. CHEN; Rebeccah LUU; Anant CHOPRA
- Web page: https://patentgrep.com/patent/US20190316068A1

## CPC

- B33Y 80/00: Products made by additive manufacturing
- C12M 21/08: {for producing artificial tissue or for ex-vivo cultivation of tissue (prostheses A61F2/00, grafts A61L27/00)}
- C12M 41/36: {of biomass, e.g. colony counters or by turbidity measurements (electrooptical investigation of individual particles G01N15/14, flow cytometers G01N15/1404)}
- C12M 41/46: {of cellular or enzymatic activity or functionality, e.g. cell viability}
- C12N 5/0062: {General methods for three-dimensional culture}
- C12N 5/0606: {Pluripotent embryonic cells, e.g. embryonic stem cells [ES] (embryonic germ cells C12N5/0611, induced pluripotent stem cells C12N5/0696)}
- C12N 5/0657: {Cardiomyocytes; Heart cells}
- C12N 5/0696: {Artificially induced pluripotent stem cells, e.g. iPS}
- C12M 23/12: {Well or multiwell plates (C12M25/04 takes precedence)}
- C12M 25/14: {Scaffolds; Matrices (in general C12N5/0068)}
- C12N 2501/33: Insulin
- C12N 2501/415: Wnt; Frizzeled
- C12N 2502/1323: Adult fibroblasts
- C12N 2502/1388: Mesenchymal stem cells from other natural sources
- C12N 2506/45: from artificially induced pluripotent stem cells
- C12N 2513/00: 3D culture
- C12N 2529/00: Culture process characterised by the use of electromagnetic stimulation
- C12N 2531/00: Microcarriers
- C12N 2533/56: Fibrin; Thrombin
- C12N 2533/90: Substrates of biological origin, e.g. extracellular matrix, decellularised tissue
- C12N 2535/00: Supports or coatings for cell culture characterised by topography
- B33Y: ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- C12M: APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; {APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

Described herein are a system, device, methods and compositions related to generating 3-dimensional cardiac tissues. Also described herein are a system, device, and methods of maturing 3-dimensional cardiac tissues and maintaining their viability in culture.

## Claims

### Claim 1

A system for generating 3-dimensional (3D) cardiac tissues, the system comprising:
a solid support base
a well in the support base, the well including a lower chamber and an upper chamber;
at least two pillars in the lower chamber operable to produce cardiac tissues across the pillars; and
a head on top of each pillar, each of the heads protruding into the upper chamber
wherein the heads are chemically treated in a sticky coating that is different from that of the pillar.

### Claim 2 (depends on 1)

The system of claim 1, further comprising muscle cells, cardiomyocytes, or stem cells in the well.

### Claim 3 (depends on 1)

The system of claim 1, wherein the pillars are flexible and permit contraction of the cells.

### Claim 4 (depends on 1)

The system of claim 1, wherein the pillars are 0.01 to 2.0 millimeters (mm) in height.

### Claim 5 (depends on 1)

The system of claim 1, wherein a spring constant of the pillars is at least 0.05 micronewtons/micrometer (μN/μm).

### Claim 6 (depends on 1)

The system of claim 1, wherein the head on top of each pillar is spherically shaped.

### Claim 7 (depends on 1)

The system of claim 1, wherein the head on top of each pillar includes a portion overhanging the pillar.

### Claim 8 (depends on 1)

The system of claim 1, wherein the chemical treatment or sticky coating is one of plasma, poly-lysine, and/or glutaraldehyde.

### Claim 9 (depends on 1)

The system of claim 1, wherein the upper chamber is larger than the lower chamber, and wherein the upper chamber includes a tapered wall in contact with the lower chamber.

### Claim 10 (depends on 1)

The system of claim 1, further comprising:
at least one additional well having a lower chamber and an upper chamber in the solid support base comprising:
at least two pillars in the lower chamber of the another well operable to produce cardiac tissues between the pillars; and
a head on top of each pillar, each of the heads protruding into the upper chamber of the at least one additional well.

### Claim 11 (depends on 1)

The system of claim 1, further comprising an extracellular matrix in the well.

### Claim 12 (depends on 1)

The system of claim 1, wherein the solid support base is fabricated from polydimethylsiloxane (PDMS), polyurethane (PU), and/or poly(ethylene glycol) (PEG).

### Claim 13 (depends on 1)

The system of claim 1, further comprising a stimulator having an electrode that generates an electrical stimulus to the well and/or pillars.

### Claim 14 (depends on 1)

The system of claim 1, further comprising a measurement device operable for measuring contractile function of the tissue generated in the well.

### Claim 15 (depends on 1)

The system of claim 1, further comprising a device for measuring the electrical function of the tissue.

### Claim 16 (depends on 1)

The system of claim 1, further comprising cells adhered to the pillars to form the tissue spanning across the pillars.

### Claim 17

A device for generating 3-dimensional (3D) cardiac tissues, the device comprising:
a. a solid support base having a top surface;
b. a plurality of wells accessible through the top surface, each of the wells including a top well and a lower base well;
c. at least two pillars in each of the lower base wells operable to produce cardiac tissues across the pillars; and
d. a head on top of each pillar, each of the heads protruding into the corresponding top wells.

### Claim 18

A method for generating cardiac tissues, comprising:
providing a device including at least one well including a plurality of pillars coupled to the bottom surface of each of at least one well, each pillar including a head at a terminal end thereof, wherein each of at least one well is surrounded by a plurality of ridges, wherein the heads are chemically treated in a sticky coating that is different from that of the pillar;
immersing the device in a suspension of cardiomyocytes;
delivering the suspension of cardiomyocytes into at least one well;
polymerizing the suspension to form a matrix;
culturing the cardiomyocytes over time, to spontaneously compact the matrix, wherein the pillars anchor the contracting matrix, constraining the contraction of the matrix to form a band of cardiac tissue that spans across the pillars, thereby allowing the cardiomyocytes to mature; and
measuring a contractile function of the band of cardiac tissue,
wherein measuring comprises: imaging the device, over time, to acquire image data determining a force exerted on the pillars based on at least the image data and a spring constant corresponding to each pillar; and identifying a contractile function of the band of cardiac tissue based on at least the determined force,
wherein the contractile function includes one or more of beat frequency, contraction duration, change in beat frequency over time, change in contraction duration over time, or variance in any of these phenotypic characteristics.

### Claim 19 (depends on 18)

The method of claim 18, wherein the chemical treatment or sticky coating is one of plasma, poly-lysine, and/or glutaraldehyde.

### Claim 20 (depends on 18)

The method of claim 18, wherein the cardiomyocytes are stem cell-derived cardiomyocytes.

### Claim 21 (depends on 20)

The method of claim 20, wherein the stem cell-derived cardiomyocytes are differentiated from an induced pluripotent stem cell (iPS cell) or an embryonic stem cell.

### Claim 22 (depends on 20)

The method of claim 20, wherein the stem cell-derived cardiomyocytes are derived from a subject with a muscular disease or disorder.

### Claim 23 (depends on 18)

The method of claim 18, wherein the cardiomyocytes are genetically modified.

### Claim 24 (depends on 18)

The method of claim 18, further comprising, stimulating and/or measuring the electrical function of the cardiac tissue.

### Claim 25 (depends on 24)

The method of claim 24, wherein the electrical stimulation frequency is at least 0.1 Hz.

### Claim 26 (depends on 18)

The method of claim 18, wherein the cardiac tissues are viable for at least 7 days.

### Claim 27 (depends on 18)

The method of claim 18, further comprising, prior to providing a device, making the device using a 3D-printed mold and a curable polymer.

### Claim 28 (depends on 27)

The method of claim 27, wherein the curable polymer is PDMS, polyurethane (PU), or poly(ethylene glycol) (PEG).

### Claim 29 (depends on 18)

The method of claim 18, wherein the pillars are at least 0.01 millimeters (mm) in height.

### Claim 30 (depends on 18)

The method of claim 18, wherein the pillars are at least 0.6 millimeters (mm) apart.
